[ad_1]
| <img src = "http://imgsapp.diariodepernambuco.com.br/app/noticia_127983242361/2018/07/04/756530/20180704111423636325i.jpg" alt = "Adhesive sticker on the back of the patient and must be changed every 24 hours A box costs on average R $ 500, with handing over from the lab .: Ana Paula Neiva / DP |
The Department of Health signed the first contract for the purchase of rivastigmine, a transdermal patch for the treatment of Alzheimer's disease (AD), one of the ten most deadly diseases in Brazil.The drug has already been incorporated by the public health system in 2016. The drug rivastigmine, already available in tablet and oral solution, is now available as a transdermal patch.From rivastigmine, the SUS also provides other drugs for the treatment of Alzheimer's disease: Donepezil, Galantamine and Memantine.
The addition of adhesive to the list of rem SUS represents an improvement in the life expectancy of some patients. Because it is put on the skin, the absorption of the drug occurs throughout the day and therefore has fewer side effects, especially in the digestive system. Rivastigmine causes an increase in a substance called acetylcholine, which is reduced in the brain of Alzheimer's disease, but the drug can cause gastrointestinal symptoms such as nausea and diarrhea, a decrease of appetite and headaches
. offers greater convenience to the caregiver because of the ease of handling and the badurance that the patient has actually received the right daily dose. Indeed, as it is a disease that primarily affects the elderly, the tablets are often lost before being put in the mouth or not being swallowed by the patient. On average, in the pharmacies, the box of 30 stickers of 10 cm is marketed for 500 R $, already deduced from the laboratory.
Caused by the progressive death of brain cells, Alzheimer's disease is a neurodegenerative disease. Patients with impaired memory, in addition to attention, orientation and language, have serious consequences for their quality of life. The disease has no cure.
Worldwide, it is estimated that 47 million people suffer from dementia and each year about 10 million new cases are recorded. According to the World Health Organization (WHO), AM represents 60 to 70% of dementia cases, which represents a loss of quality of life for patients and their families.
The department explains that the addition of the adhesive version to the list made available by SUS is due to the lower side effects and the ease of application. "Rivastigmine was already administered orally, but it had the disadvantage of causing gastro-intestinal discomfort in the patient such as nausea, vomiting and diarrhea.To reduce these side effects, this new presentation has been integrated, indicated by the doctor accompanying the patient. Patients with Alzheimer's disease may take more or less medication than the prescribed amount due to forgetfulness, "says the Department of Health.
Causes and Symptoms
According to the WHO, although this disease mainly affects the elderly, the onset of symptoms before the age of 65 represents approximately 9% of cases. The disease is badociated with the abnormal appearance of senile plaques in the brain, resulting from the deposition of beta-amyloid protein. In addition, it is related to neurofibrillary tangles, fruit of hyperphosphorylation of tau protein.
In the beginning, the signs of the disease may be subtle, but they are aggravated over time. Among the main symptoms are the difficulty of memory (especially recent events), the vague speech during the conversations, the delay in the routine activities, the forgetting of the known people and places, the deterioration of the social skills and the Emotional Unpredictability
. the public health system should provide free access to the complete treatment of the disease, involving the indicated drug. For this, the patient must seek his doctor to guide him in the process of obtaining the drug. According to the Ministry of Health's Clinical Treatment Protocol (PCDT), geriatricians, neurologists, psychiatrists or any other doctor specializing in the treatment of dementias may prescribe drugs for the treatment of Alzheimer's disease ]
The adhesive is stuck to the back of the patient every 24 hours. It can be wet during swimming but must be removed the next day after use. Because it is placed on the skin, the adhesive can sometimes bring some feedback to the site of its placement and therefore it is recommended a rotation at the point of use of the product. ;adhesive.
HOW TO GET TO SUS
Where medicine is already available in the health units responsible for the distribution of this type of medicine. But patients must meet the eligibility criteria for clinical protocols and treatment guidelines and submit the documents to a designated health facility: [196459]
Copy of proof of residence
[ad_2]
Source link
